Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.24% | 349.23 | 0.0% | $6645.11m | |
| BNTX | BioNTech SE | 3.67% | 340.39 | 0.0% | $1133.09m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 3.80% | 10.92 | 0.7% | $763.35m | |
| NVAX | Novavax, Inc. | 3.28% | 185.21 | 79.8% | $670.32m | |
| AMGN | Amgen, Inc. | -0.37% | 240.64 | 1.3% | $497.38m | |
| BIIB | Biogen, Inc. | 1.87% | 332.84 | 1.7% | $439.32m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.61% | 198.34 | 1.9% | $408.06m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 68.29 | 1.0% | $401.30m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.44% | 577.16 | 2.7% | $355.46m | |
| ILMN | Illumina, Inc. | -0.14% | 495.07 | 3.5% | $263.65m | |
| NTLA | Intellia Therapeutics, Inc. | -2.21% | 138.72 | 2.3% | $258.07m | |
| CRSP | CRISPR Therapeutics AG | 1.82% | 123.22 | 0.6% | $147.36m | |
| EXAS | EXACT Sciences Corp. | 1.83% | 109.81 | 18.1% | $125.85m | |
| SGEN | Seagen Inc. | 0.86% | 154.71 | 5.8% | $121.26m | |
| XBIO | Xenetic Biosciences, Inc. | 16.22% | 4.73 | 0.0% | $118.75m |
Company Profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.